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The inauguration of Cell Communication & Signaling
includes the introduction of a Commentary section which
will identify concepts and current research of interest to
the readership. In this first Commentary I have high-
lighted the complex processes of cartilage and bone for-
mation and the potential role of the CCN family of
proteins, in particular CCN2 (CTGF). We invite authors of
papers cited and other investigators interested in the sub-
ject areas to submit further insights via the Commentary
section and indeed in this manner to help develop a lively
forum for discussion and interaction.
In its simplest organizational perspective, a committed
mesenchyme initiates formation of cartilage where differ-
entiating chondroblasts progress to become chondrocytes
and in doing so lay down a highly specialized extracellular
matrix. Hypertrophy of one zone of chondrocytes and
death through apoptosis set the framework for ensuing
stages in osteogenesis, beginning with a scaffold for grow-
ing bone, and then vascularization of the territory which
then brings in osteoblasts and osteoclasts to initiate for-
mation of trabecular bone further remodeling and therein
the development of a second prominent and unique
extracellular matrix. The list of morphogenetic factors,
growth factors, steroids and key transcription factors that
orchestrate this complex process is already extensive and
continues to grow, almost mimicking the process itself
[1,2]. Outside to inside and vice versa signaling events are
critical to the process of cartilage and bone formation
since the different cell populations involved must coordi-
nate their activities in order to realize the ultimate ana-
tomical structure. Thus it is not surprising that disruptions
in these intricate communications and loss of factors
would lead to development of mild to severe abnormali-
ties. Add to this the importance of precise timing of sign-
aling events and attention to physiologically effective
concentrations of factors that dictate growth, differentia-
tion and apoptosis, it is evident that specific molecules are
needed to assist in 'pacing' the developmental steps. In
this first Commentary we highlight a number of reviews
and studies that address the complex biology of cartilage
and bone formation, a prime example of cell-cell interac-
tion, communication through diffusible factors, and criti-
cal signaling pathways of cell behavior that are inimical to
the development of the skeleton. While these processes
require a variety of growth factors and hormones we bring
attention to one member of the CCN family of genes [3],
CCN2(CTGF), that plays a key role in building cartilage
and bone tissues.
The work stemming from the laboratory of Dr. Takigawa
and colleagues [4–6] focuses on the role that CCN2 plays
in bone formation and particularly in the vascularization
events. CCN2 has multiple effects on a number of cell
types promoting chemotaxis, migration, adhesion, prolif-
eration, differentiation and /or extracellular matrix forma-
tion. CCN2 is maximally expressed in hypertrophic
chondrocytes prior to the initiation of osteogenesis and
angiogenesis. CCN2 shares homology with other mem-
bers of the CCN family noted for their molecular organi-
zation into basically four structural domains: an IGFBP
module, a von Willebrand type C repeat, a thrombospon-
din type 1 repeat and a C-terminal module; these modules
are involved in protein-protein interactions and associa-
tions with components of the extracellular matrix. The
definitive functions of these modules has still to be
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worked out, but their homology to the larger parent mol-
ecules suggest possibilities for multiple protein partners
and intricate modulatory functions. CCN family proteins,
and their isoforms, are distributed intracellularly as well
as extracellularly [3]. In other words, nature appears to
have imbued CCN2 and likely the other CCN proteins
with structural features that could integrate them into
intracellular as well as extracellular molecular machines.
The challenge will be to understand the full complexity of
their activities, biological functions, and clinical relevance
[3].
More recent studies by Safadi et al [7], Ivkovic et al [8],
and Friedrichsen et al [9] place CCN2 squarely in the
limelight as critical for cartilage and bone formation from
earliest developmental stages to later fetal and post-natal
stages of skeletal growth. In fact, CCN2 expression persists
in vascular endothelium, condensed connective tissue
around bone and cartilage, and maturing layer VII neu-
rons in the cerebral cortex. CCN2 knockout mice exhibit
skeletal dysmorphisms as a result of impaired chondro-
genesis. Thus CCN2 appears not to be rescued by other
CCN members. So, although many macromolecules fig-
ure prominently in formation of cartilage and bone, spe-
cific CCN proteins appear to be key players in mediating
development of cartilage and bone from first conception.
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